论文信息 - A randomized phase II clinical trial of the SRC inhibitor saracatinib (AZD0530) and carboplatin plus paclitaxel (C plus P) versus C plus P in patients (pts) wiht advanced platinum-sensitive epithelial ovarian cancer (eoc) - 字舞流文

A randomized phase II clinical trial of the SRC inhibitor saracatinib (AZD0530) and carboplatin plus paclitaxel (C plus P) versus C plus P in patients (pts) wiht advanced platinum-sensitive epithelial ovarian cancer (eoc)

Gunnar B. Kristensen | S. Rodenhuis | C. Poole | G. Kristensen | Christopher J. Poole | A. Lisyanskaya | S. Rodenhuis | E. Pujade Lauraine | M. Cantarini | U. Emeribe | M. Stuart | I. Ray Coquard | A. Lisyanskaya | E. P. Lauraine | M. Stuart | M. Cantarini | U. Emeribe | I. Coquard